Breathe Well Live Well
|
GSK runs to PhIII with upbeat data on drug for severe asthma
FierceBiotech GlaxoSmithKline ($GSK) generated positive results from a mid-stage trial for its experimental drug in patients with an uncommon form of asthma, giving the London drug giant confidence in advancing the program to Phase III development before the end of … |
View full post on asthma – Google News
 NutraIngredients-usa.com |
Carotenoids may improve asthma symptoms: RCT data
NutraIngredients-usa.com Consumption of an antioxidant-rich diet led to improvements in both lung capacity and longer times for an asthmatic attack to worsen, according to findings published in the American Journal of Clinical Nutrition. Researchers from the University of … |
View full post on asthma – Google News
|
IBM team encourages Louisville to share data to fight asthma
The Courier-Journal The city of Louisville was shrouded in smog on a very hot day. Today was declared an air quality alert day. Ozone and Particle pollution was expected to be in the unhealthy range for sensitive groups. _ (By Pam Spaulding, The Courier-Journal)_August 2, … |
View full post on asthma – Google News
 Medgadget.com |
Asthma inhaler transmits your usage data to your smartphone
New York Daily News Next in line in the world of smart health devices: a sensorized asthma inhaler that tracks your usage and transmits the data to your smartphone. Asthmapolis Receives FDA Clearance for Asthma Inhaler Sensor System FDA Clearance for Asthmapolis' Asthma Inhaler Sensor |
View full post on asthma – Google News
Medgadget.com |
Asthma inhaler transmits your usage data to your smartphone
Yahoo! Philippines News Read 'Asthma inhaler transmits your usage data to your smartphone' on Yahoo! OMG! Philippines. Next in line in the world of smart health devices: a sensorized asthma inhaler that tracks your usage and transmits the data to your smartphone. Inhaler … Asthmapolis Receives FDA Clearance for Asthma Inhaler Sensor System |
View full post on asthma – Google News
|
Promising Phase II Data For Tiotropium In Adolescent Asthma Patients
Science 2.0 [1] Boehringer Ingelheim announced that the company has a comprehensive confirmatory phase III trial programme named UniTinA-asthma(TM) ongoing to fully evaluate the potential of the long-acting bronchodilator in the treatment of asthma. |
View full post on asthma – Google News
|
Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with …
PR Newswire (press release) Boehringer Ingelheim announced that a comprehensive confirmatory Phase III trial program named UniTinA-asthma™ is ongoing to fully evaluate the potential of the long-acting bronchodilator in the treatment of asthma in pediatric, adolescent and adult … Promising Phase II Data With Once-Daily Tiotropium may Lead to New Treatment … Results of Phase II Study of Boehringer Ingelheim's Investigational … |
View full post on asthma – Google News
|
Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with …
MarketWatch (press release) Boehringer Ingelheim announced that a comprehensive confirmatory Phase III trial program named UniTinA-asthma(TM) is ongoing to fully evaluate the potential of the long-acting bronchodilator in the treatment of asthma in pediatric, adolescent and adult … Boehringer Ingelheim Announces Positive Phase II Results for Once-Daily … Results of Phase II Study of Boehringer Ingelheim's Investigational … |
View full post on asthma – Google News
|
Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled …
MarketWatch (press release) "We are strongly committed to advancing a pipeline of iCALM therapies to treat chronic respiratory diseases, including COPD, asthma and cystic fibrosis." "iCALM's ability to limit allergen-induced eosinophilic airway inflammation in this trial is … |
View full post on asthma – Google News
 Daily Mail |
Positive SNG001 Phase II Asthma Clinical Trial Data
Science 2.0 (press release) This pioneering trial investigated the potential for SNG001 (inhaled interferon beta) to protect asthmatics from respiratory virus infections (principally the common cold) that can spread to the lung, which are a major cause of worsening asthma … Asthma drug 'protects sufferers from life-threatening symptoms caused by … Synairgen's 'breakthrough' asthma drug shines in Phase II trial New drug 'reduces asthma symptoms' |
View full post on asthma – Google News